Suliman Boulos, our newly appointed CEO, brings with him great passion and drive in the field of drug discovery and precision medicine. Having the heart of an oncologist and the mindset of a scientist, Suliman is taking Curigin to new horizons in the field of oncolytic gene therapy. He is leading our team with a clear message, “At the end of the day, what we achieve can influence greatly the lives of many people around the globe”.

• NationalityIsrael
• EducationBoard-certified Medical Oncologist
• LanguagesArabic, Hebrew, English, German, Basic Korean
• Leisure timeTable tennis, hiking, movies, spending time with family and friends